Reference health
Plasma levels of interleukin-6 and antidepressant response to Paroxetine in Chinese depressive patients
38/38 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 38 checked references that resolve
resolves10.1016/j.jpsychires.2018.02.011
Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
resolves10.1089/cap.2015.0147
The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders
resolves10.1016/j.psychres.2018.08.078
Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
resolves10.1016/j.pnpbp.2007.09.015
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
resolves10.1038/mp.2015.168
Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression
resolves10.1517/13543784.2014.998334
Novel investigational drugs targeting IL-6 signaling for the treatment of depression
resolves10.4088/JCP.14m09298
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
resolves10.1038/npp.2011.132
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
resolves10.1038/npp.2011.205
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
resolves10.1016/j.bbi.2012.06.001
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
resolves10.1016/j.psyneuen.2017.01.023
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
resolves10.1016/j.jad.2018.06.045
The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature
resolves10.1159/000484665
Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder
resolves10.1001/jama.289.23.3152
Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression
resolves10.1038/tp.2017.31
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
resolves10.1038/srep09009
STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior
resolves10.1016/j.bbi.2019.01.027
JAK2/STAT3 signaling mediates IL-6-inhibited neurogenesis of neural stem cells through DNA demethylation/methylation
resolves10.1016/S0893-133X(99)00134-7
Cytokine Production and Treatment Response in Major Depressive Disorder
resolves10.30773/pi.2019.0117
C-Reactive Protein Gene Variants in Depressive Symptoms & Antidepressants Efficacy
resolves10.1016/j.chc.2012.01.001
Child and Adolescent Depression Intervention Overview: What Works, for Whom and How Well?
resolves10.1006/cyto.1997.0238
INCREASED SERUM IL-6 AND IL-1 RECEPTOR ANTAGONIST CONCENTRATIONS IN MAJOR DEPRESSION AND TREATMENT RESISTANT DEPRESSION
resolves10.1016/j.biopsych.2008.11.029
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
resolves10.1038/s41598-018-30487-6
IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis
resolves10.1001/2013.jamapsychiatry.4
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
resolves10.1038/mp.2015.22
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
resolves10.1016/j.euroneuro.2015.06.007
Inflammation and clinical response to treatment in depression: A meta-analysis
resolves10.1002/phar.1576
Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment‐Resistant Depression
resolves10.1016/j.jad.2009.02.013
Body weight as a predictor of antidepressant efficacy in the GENDEP project
resolves10.1176/appi.ajp.2014.14010094
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
resolves10.1016/S0889-1591(02)00006-5
Neopterin production, tryptophan degradation, and mental depression—What is the link?
resolves10.1016/j.jad.2019.07.045
Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review
resolves10.1016/j.biopsych.2014.06.021
Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
resolves10.1002/hup.2333
Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
resolves10.1016/j.pnpbp.2009.03.020
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
The 1 reference without a DOI — listed, not checked
no DOI — not checkedThe increasing burden of depression
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.psychres.2021.113723"><img src="https://citestamp.com/citestamped/10.1016/j.psychres.2021.113723/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.psychres.2021.113723)